The transaction targeted 792,965 shares valued at RON20.8 million, at the trading price on the Bucharest Stock Exchange. One Medlife share traded down 0.38% at RON26.3 Friday morning.
British investment management firm Charlemagne Capital was acquired by Fiera Capital Corporation in 2016. Fiera Capital’s European division is registered in the Isle of Man.
In Romania, Charlemagne was previously involved in investments in residential compound Asmita Gardens, which subsequently entered insolvency.
MedLife has a market capitalization of RON584 million. The Marcu Family directly owns 45% of the company’s share capital.
MedLife Group reported a turnover of RON374 million in the first half of 2018, up 24% year-on-year, and a net profit of RON6 million, down 5% on the year.